1. Home
  2. BHVN vs RIG Comparison

BHVN vs RIG Comparison

Compare BHVN & RIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • RIG
  • Stock Information
  • Founded
  • BHVN 2013
  • RIG 1926
  • Country
  • BHVN United States
  • RIG Switzerland
  • Employees
  • BHVN N/A
  • RIG N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • RIG Oil & Gas Production
  • Sector
  • BHVN Health Care
  • RIG Energy
  • Exchange
  • BHVN Nasdaq
  • RIG Nasdaq
  • Market Cap
  • BHVN 1.9B
  • RIG N/A
  • IPO Year
  • BHVN 2017
  • RIG 1993
  • Fundamental
  • Price
  • BHVN $20.25
  • RIG $2.50
  • Analyst Decision
  • BHVN Strong Buy
  • RIG Hold
  • Analyst Count
  • BHVN 14
  • RIG 8
  • Target Price
  • BHVN $62.92
  • RIG $4.36
  • AVG Volume (30 Days)
  • BHVN 2.2M
  • RIG 40.6M
  • Earning Date
  • BHVN 05-16-2025
  • RIG 04-28-2025
  • Dividend Yield
  • BHVN N/A
  • RIG N/A
  • EPS Growth
  • BHVN N/A
  • RIG N/A
  • EPS
  • BHVN N/A
  • RIG N/A
  • Revenue
  • BHVN N/A
  • RIG $3,667,000,000.00
  • Revenue This Year
  • BHVN N/A
  • RIG $10.24
  • Revenue Next Year
  • BHVN $65.26
  • RIG $2.91
  • P/E Ratio
  • BHVN N/A
  • RIG N/A
  • Revenue Growth
  • BHVN N/A
  • RIG 24.47
  • 52 Week Low
  • BHVN $15.79
  • RIG $1.97
  • 52 Week High
  • BHVN $55.70
  • RIG $6.38
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 43.84
  • RIG 52.32
  • Support Level
  • BHVN $18.99
  • RIG $2.27
  • Resistance Level
  • BHVN $24.06
  • RIG $2.45
  • Average True Range (ATR)
  • BHVN 2.03
  • RIG 0.14
  • MACD
  • BHVN 0.24
  • RIG 0.06
  • Stochastic Oscillator
  • BHVN 42.62
  • RIG 89.36

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: